Safety of Initiation of Sacubitril/Valsartan in ICU Patients With Advanced Decompensated Heart Failure

Journal of Cardiac Failure - United States
doi 10.1016/j.cardfail.2019.07.206
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Tolerability, Safety, and Hemodynamics of Sacubitril-Valsartan in Acutely Decompensated Heart Failure Patients With Cardiogenic Shock

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Experience of Hospital Initiation of Sacubitril/Valsartan in a Female Patient After Acute Decompensated Heart Failure

Kardiologiya
Cardiovascular MedicineCardiology
2018English

Sacubitril-Valsartan in Heart Failure and Multimorbidity Patients

ESC heart failure
Cardiovascular MedicineCardiology
2018English

Perceived Barriers to Sacubitril/Valsartan Use in Patients With Heart Failure

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2018English

Reply: Sacubitril/Valsartan for Chagas' Heart Disease Heart Failure?

ESC heart failure
Cardiovascular MedicineCardiology
2018English

Pcv6 - Sacubitril/Valsartan in Heart Failure: Projected Health Outcomes in Portugal

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Evaluating the Safety and Tolerability of Inpatient Sacubitril/Valsartan Initiation in a Community Hospital

Journal of Community Hospital Internal Medicine Perspectives
Internal Medicine
2020English

Nesiritide Enhances Urine Output in Decompensated Advanced Heart Failure Patients

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2017English

Cost-Effectiveness of Sacubitril/Valsartan in the Treatment of Heart Failure in Colombia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy